The Germany Actinic Keratosis Therapeutic Market is expected to grow at a CAGR of 3.10%, rising from $249 Mn in the year 2022 reaching $318 Mn by the year 2030. The rising incidence of actinic keratosis, improvements in treatment options, rising public awareness and screening programs, encouraging government initiatives, technological advancements, an aging population, market competition, and patient preferences are the factors driving the Germany Actinic Keratosis Therapeutic Market. The key players in the Germany Actinic Keratosis Therapeutic Market include Bayer, Galderma, Pierre Fabre, Chemiplastics, Oncopharma, Aclaris Therapeutics, Varens, Photocure, Meda Pharma etc.
Egypt Constipation Therapeutics Market was valued at $51 Mn in 2022 and is estimated to reach $94 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The global growth of the constipation therapeutics market is driven by factors such as aging, sedentary lifestyles, and unhealthy dietary habits. The increasing elderly population, susceptible to chronic conditions, notably contributes to this expansion. Major players in this sector comprise Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Merck & Co., Novartis, and Pfizer.
The Philippines Mental Health Apps Market was valued at $13.64 Mn in 2023 and is predicted to grow at a CAGR of 15.7% from 2023 to 2030, to $37.86 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, a shortage of professionals, and government support. The industry is primarily dominated by players such as Calm, Happify, Ten Percent Happier, and Lusog-Isip among others.
The Canada Herbal Supplements Market was valued at $420.80 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $641.13 Mn by 2030. The key drivers of this industry include growing health awareness, preference for natural products, and aging population. The industry is primarily dominated by players such as Nature’s Way, New Chapter, New Roots Herbal, Botanica Health, and Herbalife among others.
The Vietnam Bio-implant Market was valued at $325 Mn in 2023 and is predicted to grow at a CAGR of 6.13% from 2023 to 2030, to 492.9 Mn by 2030. The Vietnam Bio-implant Market is growing due to like Increasing Disposable Income and Health Awareness, Growing Aging Population, Government Initiatives and Support. The market is primarily dominated by players such as Orthopaedic International, OrthoMed, Medline Vietnam, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
South Africa Lipid Disorder Therapeutics Market was valued at $252.5 Mn in 2023 and is predicted to grow at a CAGR of 13.63% from 2023 to 2030, to $617.6 Mn by 2030. South Africa Lipid Disorder Therapeutics Market is growing due to Advancements in Therapeutics, Increasing Healthcare Expenditure, and the Rising Prevalence of Cardiovascular Diseases (CVDs). The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
France Constipation Therapeutics Market was valued at $501 Mn in 2022 and is estimated to reach $768 Mn in 2030, exhibiting a CAGR of 5.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by rising global rates of constipation associated with factors like aging, sedentary lifestyles, and poor dietary habits, as well as the expanding elderly population, which is particularly prone to chronic conditions. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Ipsen Pharma, Johnson & Johnson, Norgine Pharmaceuticals, Pierre Fabre Médicament, Recordati and Sanofi.
The Singapore Mental Health Apps Market was valued at $7.44 Mn in 2023 and is predicted to grow at a CAGR of 15.8% from 2023 to 2030, to $20.77 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, rising awareness, and government support. The industry is primarily dominated by players such as Calm, Happify, Headspace, and MindFi among others.
The US Herbal Supplements Market was valued at $2209.20 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $2946.52 Mn by 2030. The key drivers of this industry include increasing health consciousness, rising stress levels, and an aging population. The industry is primarily dominated by players such as Amway, Nature Made, Youtheory, Natrol, and Vitafusion among others.
The Philippines Bio-implant Market was valued at $143 Mn in 2023 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to 220.8 Mn by 2030. The Philippines Bio-implant Market is growing due to like the Aging Population, Growing Medical Tourism Industry, and Government Healthcare Initiatives. The market is primarily dominated by players such as Orthopaedic International, OrthoMed, Medline Philippines, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
The India Lipid Disorder Therapeutics Market was valued at $151.5 Mn in 2023 and is predicted to grow at a CAGR of 12.88% from 2023 to 2030, to $353.8 Mn by 2030. India Lipid Disorder Therapeutics Market is growing due to the Prevalence of cardiovascular diseases, Consumer preference for over-the-counter (OTC) drugs, Advancements in Therapeutics, and Growing Healthcare Expenditure and Infrastructure. The industry is primarily dominated by players such as Sun Pharmaceutical Industries Ltd., Cipla, Lupin, Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie, Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Japan Castrate Resistant Prostate Cancer Therapeutics Market valued at $634 Mn in 2022, projected to reach $1139 Mn by 2030 with a 7.6% CAGR. The key driver of the market in Japan is the significant surge in the aging population, particularly those at higher risk of age-related cancers, coupled with increased diagnostics, screening, and a growing awareness of the disease and treatment options. The Japan Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Sanofi, Bayer, Astellas, AbbVie, Eisai, Novartis, AstraZeneca, Bristol-Myers Squibb, etc, among various others.
Germany Constipation Therapeutics Market was valued at $666 Mn in 2022 and is estimated to reach $962 Mn in 2030, exhibiting a CAGR of 4.7% during the forecast period. The constipation therapeutics market is experiencing growth driven by rising global rates of constipation associated with factors like aging, sedentary lifestyles, and poor dietary habits, as well as the expanding elderly population, which is particularly prone to chronic conditions. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Ipsen Pharma, Johnson & Johnson, Norgine Pharmaceuticals, Pierre Fabre Médicament, Recordati, and Sanofi.
The Vietnam Mental Health Apps Market was valued at $31 Mn in 2023 and is predicted to grow at a CAGR of 15.43% from 2023 to 2030, to $84.64 Mn by 2030. The key drivers of this industry include increasing smartphone penetration, rising awareness, and rising interest in preventive care. The industry is primarily dominated by players such as Calm, Happify, Headspace, and Wysa among others.
The Saudi Arabia Herbal Supplements Market was valued at $89.42 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $150.30 Mn by 2030. The key drivers of this industry include health consciousness, preventive healthcare trends, and the young population. The industry is primarily dominated by players such as Himalaya Wellness, NOW Foods, Botanic Supplements, and Dabur among others.
The Egypt Bio-implant Market was valued at $182 Mn in 2023 and is predicted to grow at a CAGR of 7.4/% from 2023 to 2030, to $300 Mn by 2030. The Egypt Bio-implant Market is growing due to like Increasing Chronic Disease Prevalence, Rising Disposable Income and Healthcare Spending, and Technological Innovations in Implant Materials. The market is primarily dominated by players such as Alexandria Advanced Technologies, Medica Egypt, Misr Medicare, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Kenya Actinic Keratosis Therapeutic Market is expected to expand at a CAGR of 6% from $5 Mn in 2022 to $8 Mn by 2030. The market is expected to grow as a result of rising prevalence combined with specific environmental variables, a shifting economic landscape, rising disposable incomes, and more access to healthcare services in Kenya. International and local players Galderma, Bayer, Novartis, Mediheal Pharmaceuticals, Mifa, Kepharth etc, contribute to the therapeutic management of Actinic Keratosis
China Castrate Resistant Prostate Cancer Therapeutics Market valued at $28 Mn in 2022, projected to reach $450 Mn by 2030 with a 6.10% CAGR. The key drivers of this market are the rapidly aging population in China, with an increasing risk of prostate cancer, coupled with the evolving healthcare system reforms, increased government investment, and accessibility of innovative CRPC therapies by multinational pharmaceutical companies. The China Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Roche, Bayer, AstraZeneca, Sanofi, BeiGene, Innovent Biopharmaceuticals, Shanghai Junshi Biosciences, Henlius Biotech, etc, among various others.
Indonesia Constipation Therapeutics Market was valued at $109 Mn in 2022 and is estimated to reach $181 Mn in 2030, exhibiting a CAGR of 6.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Roche, and Sanofi.
The Egypt Mental Health Apps Market was valued at $17.36 Mn in 2023 and is predicted to grow at a CAGR of 16.7% from 2023 to 2030, to $51.17 Mn by 2030. The key drivers of this industry include government support, rising awareness, and increasing demand. The industry is primarily dominated by players such as Calm, Happify, Headspace, and Safe Space among others.
The UAE Herbal Supplements Market was valued at $26.30 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $42.79 Mn by 2030. The key drivers of this industry include health and wellness trends, cultural influence, and government initiatives. The industry is primarily dominated by players such as Himalaya Wellness, Dabur, Herbalife Nutrition, and Healwell Pharma among others.
The India Bio-implant Market was valued at $1182.1 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to 2147.1 Mn by 2030. The India Bio-implant Market is growing due to like Rising Incidence of Chronic Diseases, Rising Disposable Income, Increasing Awareness, and Patient Education. The market is primarily dominated by players such as Sahajanand Medical Technologies, Biorad Medisys, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Japan Constipation Therapeutics Market was valued at $1131 Mn in 2022 and is estimated to reach $1944 Mn in 2030, exhibiting a CAGR of 7% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Roche, and Sanofi.
The Kenya Mental Health Apps Market was valued at $4.34 Mn in 2023 and is predicted to grow at a CAGR of 16.3% from 2023 to 2030, to $12.49 Mn by 2030. The key drivers of this industry include government support, rising awareness, and increasing smartphone penetration. The industry is primarily dominated by players such as Calm, Happify, Headspace, and Wazi among others.
The Brazil Herbal Supplements Market was valued at $131.50 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $213.94 Mn by 2030. The key drivers of this industry include health awareness, government support, and growth in the wellness industry. The industry is primarily dominated by players such as Herbalife, Himalaya, NOW Foods, and Botanic Supplements among others.